首页> 美国卫生研究院文献>Schizophrenia Bulletin >10.4 MAPPING NEURO-BEHAVIORAL RELATIONSHIPS IN DIMENSIONAL GEOMETRIC EMBEDDING (N-BRIDGE) VIA PHARMACOLOGY COMPUTATION AND CLINICAL NEUROIMAGING: UNIFYING CATEGORIES AND DIMENSIONS ALONG THE PSYCHOSIS SPECTRUM
【2h】

10.4 MAPPING NEURO-BEHAVIORAL RELATIONSHIPS IN DIMENSIONAL GEOMETRIC EMBEDDING (N-BRIDGE) VIA PHARMACOLOGY COMPUTATION AND CLINICAL NEUROIMAGING: UNIFYING CATEGORIES AND DIMENSIONS ALONG THE PSYCHOSIS SPECTRUM

机译:10.4通过药理学计算和临床神经影像学在二维几何嵌入(N桥)中映射神经行为关系:统一精神病谱的类别和维度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A key challenge in the field of neuropsychiatry lies in matching patients with effective treatments. Most studies in psychiatry operate under the canonical assumption that categorical diagnostic clinical grouping and/or pre-existing clinical assessments are the ‘gold standard’ for describing behavioral - and therefore neural - variation in patients. Attempts to robustly characterize the neural substrates of these predefined variables have yielded limited success, suggesting an inadequate mapping to neurobiologically meaningful variation. Notably, a great deal of heterogeneity exists even within groups of patients with the same categorical diagnosis. Thus, understanding the mapping between specific behaviors and clinically-meaningful variation in neural properties is critical to develop and ultimately administer effective individualized neurobehavioral treatments.
机译:神经精神病学领域的关键挑战在于为患者提供有效的治疗方法。精神病学的大多数研究都是在规范的假设下进行的,即分类诊断临床分组和/或预先存在的临床评估是描述患者行为乃至神经变异的“黄金标准”。试图强健地表征这些预定义变量的神经底物的尝试仅获得了有限的成功,表明对神经生物学有意义的变异的映射不足。值得注意的是,即使在具有相同分类诊断的患者组中也存在大量异质性。因此,了解特定行为与神经特性的临床意义变异之间的映射对于开发并最终实施有效的个体化神经行为治疗至关重要。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号